Succinimide

Succinimide

SCHEMBL73277

C=C(C)C(=O)O.O=C1CCC(=O)N1

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 6/20 0.52
DDB1 Q16531 2/20 0.35
ITGB3 P05106 1/20 0.32
ITGB1 P05556 1/20 0.32
ITGAV P06756 1/20 0.32
ITGA4 P13612 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
NPC1 O15118 1/20 0.30
MAPK13 O15264 1/20 0.30
MAPK12 P53778 1/20 0.30
MAPK11 Q15759 1/20 0.30
MAPK14 Q16539 1/20 0.30
USP2 O75604 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methacrylic Acid SCHEMBL9722957 0.91 CRBN (0.56) CRBNDDB1ITGB3ITGB1ITGAV
Succinimide SCHEMBL169754 0.85 CRBN (0.65) CRBNTDP1KDM4EALDH1A1NPC1
Succinimide SCHEMBL11381109 0.85 CRBN (0.65) CRBNDDB1ITGB3ITGB1ITGAV
Succinimide SCHEMBL30804677 0.85 CRBN (0.65) CRBNDDB1ITGB3ITGB1ITGAV
Succinimide SCHEMBL8060686 0.85 CRBN (0.65) CRBNTDP1KDM4EALDH1A1NPC1
Succinimide SCHEMBL3262638 0.85 CRBN (0.65) CRBNTDP1KDM4EALDH1A1NPC1
Succinimide SCHEMBL28381869 0.85 CRBN (0.65) CRBNTDP1KDM4EALDH1A1NPC1
Succinimide SCHEMBL6823086 0.82 CRBN (0.61) CRBNTDP1KDM4EALDH1A1NPC1
Succinimide SCHEMBL28252314 0.82 CRBN (0.61) CRBNDDB1TDP1KDM4EALDH1A1
Succinimide SCHEMBL27948934 0.82 CRBN (0.61) CRBNTDP1KDM4EALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102796224-A Multifunctional bionic polymer, its preparation method and application LIPING LIU 2012-11-28 CN claimed
CN-103649715-B It is suitable for the sample container and Sample preservation and its method of sound wave discharge 拉伯赛特股份有限公司 2018-01-16 CN disclosed
CN-102796224-A Multifunctional bionic polymer, its preparation method and application LIPING LIU 2012-11-28 CN disclosed
US-8129505-B2 Formed by catalytic polymerization; antibody conjugates UCB PHARMA S.A. (BE) 2012-03-06 US disclosed
EP-1926757-B1 ANTIBODY-COMB POLYMER CONJUGATE UCB PHARMA SA (BE) 2012-02-22 EP disclosed
US-20080220005-A1 Comb Polymers UCB PHARMA S.A. (BE) 2008-09-11 US disclosed
EP-1926757-A1 COMB POLYMERS UCB Pharma, S.A. (BE) 2008-06-04 EP disclosed
US-20070219330-A1 Amide initiators WARWICK EFFECT POLYMERS LIMITED (GB) 2007-09-20 US disclosed
WO-2007083097-A1 LIVING RADICAL POLYMERISATION PROCESS WARWICK EFFECT POLYMERS LTD. (GB) 2007-07-26 WO disclosed
WO-2007031734-A1 COMB POLYMERS UCB PHARMA S.A. (BE) 2007-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080220005-A1 Comb Polymers C9, F13B, PYM1 CRBN 748/4885DDB1 1817/4885ITGB3 390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.